Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 38,900 Shares of Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John Farquhar sold 38,900 shares of the business’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $55.74, for a total transaction of $2,168,286.00. Following the sale, the chief executive officer owned 251,983 shares in the company, valued at approximately $14,045,532.42. This trade represents a 13.37% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

John C.M. Farquhar also recently made the following trade(s):

• On Monday, October 12th, John Farquhar sold 38,900 shares of Heartflow stock. The stock was sold at an average price of $49.57, for a total transaction of $1,928,273.00.
• On Friday, September 11th, John Farquhar sold 3,890 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $194,500.00.
• On Thursday, September 10th, John Farquhar sold 35,010 shares of Heartflow stock. The shares were sold at an average price of $46.42, for a total transaction of $1,625,164.20.
• On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00.
• On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total transaction of $1,470,420.00.
• On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The stock was sold at an average price of $39.06, for a total transaction of $607,773.60.

Heartflow Price Performance

Shares of NASDAQ HTFL traded down $0.86 on Tuesday, reaching $55.80. 1,276,518 shares of the company’s stock traded hands, compared to its average volume of 1,611,085. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $60.56. The business’s 50 day simple moving average is $51.56 and its two-hundred day simple moving average is $34.87.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. The firm had revenue of $64.08 million for the quarter. Heartflow’s quarterly revenue was up 47.7% on a year-over-year basis. Analysts expect that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on HTFL shares. Benchmark reissued a “buy” rating on shares of Heartflow in a report on Friday, August 14th. Robert W. Baird set a $45.00 price target on Heartflow in a report on Friday, August 14th. Wells Fargo & Company lifted their price target on Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. Morgan Stanley upped their price target on shares of Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research note on Friday, August 14th. Finally, Piper Sandler reissued an “overweight” rating and set a $64.00 price objective (up from $45.00) on shares of Heartflow in a research report on Tuesday, October 20th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $48.62.

Institutional Investors Weigh In On Heartflow

Several institutional investors and hedge funds have recently made changes to their positions in the company. XXEC Inc. purchased a new position in Heartflow in the 2nd quarter worth approximately $2,524,764,000. BlackRock Inc. purchased a new stake in Heartflow during the 2nd quarter valued at $152,502,000. Bamco Inc. NY purchased a new stake in Heartflow during the 2nd quarter valued at $94,625,000. Jupiter Topco LLC bought a new stake in shares of Heartflow in the 2nd quarter worth $70,983,000. Finally, Janus Henderson Group PLC increased its holdings in shares of Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after purchasing an additional 1,315,416 shares in the last quarter.

Heartflow Company Profile

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.